ISIS 678354-CS15
Brief description of study
Requesting a reliance agreement with an external IRB. The purpose of this open label extension trial is to evaluate the safety and tolerability of treatment with olezarsen in subjects with severe hypertriglyceridemia who have completed the ISIS 678354-CS5 or -CS6 study with an acceptable safety profile.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
